Board of Directors
Chair of the Board
Anders Wold
MBA
Anders Wold was until recently the Business Development and Strategic Advisor to the GE Healthcare President and CEO. He was until Spring 2021 the CEO for GE Healthcare's Global Clinical Care Solution business unit with USD 5 billion is sales and over 5,000 employees. The business unit includes Ultrasound, Patient Monitoring, Anesthesia, Ventilation, Diagnostic Cardiology, Maternal Infant Care, Digital Solutions & Service. In his 38 years in the Ultrasound industry, Mr Wold has built a fast paced innovation process launching more than 20 new products every year over the last decade. The last new product added to the portfolio was the handheld Ultrasound Vscan Air™
Vice-Chair of the Board
Dr. Jonathan Allis
Phd
Dr. Jonathan Allis is a scientist turned entrepreneur and was the founding CEO of Blue Earth Diagnostics, a spin-out from GE Healthcare established in 2014. Blue Earth Diagnostics developed a prostate cancer diagnostic approved by the FDA in 2016, which became a successful product in the USA. The company was acquired by Bracco Imaging in 2019. Jonathan also served as a Board member and Chair of Polarean Imaging. Prior to these roles, Jonathan was the general manager for PET at GE Healthcare Life Sciences and was responsible for GE Healthcare’s PET agent and PET synthesis platforms business globally. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc., Siemens Medical Solutions and Oxford Magnet Technology in the UK, USA and Germany. Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in Biochemistry from the University of Oxford.
Director of Board
Dr. Masha Strømme
D.Phil (Rhodes Scholar, Oxford, Neuroscience and Genetics)
Investor and Advisor with 20+ years’ experience in the life sciences sector. Healthcare business angel. Previously Morgan Stanley and Altium Cap (UK).
Director of Board
Leiv Askvig
MBA
Leiv Askvig is an Investment Advisor for Sundt AS, and served as their CEO from 2003 to 2020. Mr Askvig has vast experience within the financial industry, and was a member of the board of Ultimovac AS. He was CEO/CFO at Opticore AB from 2001 until 2002, CFO at StudentUniverse, Inc. from 1999 until 2001 and has held various positions within investment banking at Sundal Collier & Co ASA (now "ABG Sundal Collier"). Mr Askvig holds a bachelor degree in Business Administration from BI Norwegian Business School and attended the Advanced Management course at Harvard Business School.
Director of Board
Ann-Tove Kongsnes
MBA
During her 20-year career, Ann-Tove Kongsnes has obtained extensive experience in venture capital investments in health and technology enterprises. She has also worked with M&A, IPOs and technology company exits. She currently focuses primarily on new investments and on Investinor’s portfolio companies within the health sector, including biotechs, pharmas, medtech and digital health enterprises. She also works with some of our semiconductor/deep tech companies and sits on the Boards of both listed and private companies. She holds an MSc in Economics and Business Administration from the former Bodø Graduate School of Business (HiB), and has completed the Advanced Program in Corporate Finance at the Norwegian School of Economics (NHH).
Director of Board
Flavien Daloz
MSc
Mr. Flavien Daloz is the Chief Technology Officer for Ultrasound Probes under the GEHC Advanced Visualization Solutions segment. In his 15+ years of experience, Mr. Daloz has held various leadership positions in the Medical Ultrasound industry, with a proven record in innovation and new product introductions. He was the recipient of GEHC Edison Pioneer Award in 2021 for his influence in medical ultrasound transducer breakthrough. Mr. Daloz holds an engineering degree from ESPCI school in Paris and an MSc in Bioimaging sciences from Imperial College, London. He has completed a Business Leadership Program from Michigan Ross, US.